We are live on ! Find out more
RNVAZ

Rennova Health, Inc. Warrant
RNVAZ

Delisted

RNVAZ was delisted on the 24th of October, 2017.

Back to rankings

4 hedge funds and large institutions have $16K invested in Rennova Health, Inc. Warrant in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

83% less capital invested

Capital invested by funds: $92K → $16K (-$76K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$11.1K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.44K
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$212
3
UBS Group
UBS Group
Switzerland
-$141
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$6K -$3.44K -121,476 -23%
VF
2
Virtu Financial
New York
$6K +$11.1K +392,601 New
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$4K -$212 -7,500 -3%
UBS Group
4
UBS Group
Switzerland
– -$141 -4,980 -17%

RNVAZ Hedge Fund Activity: Q3 2017 in Review

4 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. Warrant (RNVAZ) for Q3 2017, worth a combined $16K — down 83% from $92K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new RNVAZ positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $11.1K. The largest seller was Susquehanna International Group, cutting an estimated $3.44K.

  • 4 institutional investors held Rennova Health, Inc. Warrant (RNVAZ) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $16K of Rennova Health, Inc. Warrant stock for Q3 2017, down 83% quarter-over-quarter.
  • 1 fund opened new Rennova Health, Inc. Warrant positions in Q3 2017 and 0 closed out, a net change of +1 holder.
  • The largest Rennova Health, Inc. Warrant buyer in Q3 2017 was Virtu Financial, an estimated $11.1K added.
  • The largest Rennova Health, Inc. Warrant seller in Q3 2017 was Susquehanna International Group, an estimated $3.44K sold.

Based on aggregated 13F filings for Q3 2017.